Tyra Biosciences TYRA
NASDAQ TYRA
$20.45 -0.42 (-2.01%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tyra Biosciences (TYRA) Sale and Maturity of Investments (2024 - 2026)

Updated

Analysis

Tyra Biosciences (TYRA) Sale and Maturity of Investments (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Tyra Biosciences 1.22 Bn 921.98 Mn - 40.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 40.00 Mn
Mar 31, 2026 42.05 Mn
Dec 31, 2025 43.54 Mn
Sep 30, 2025 50.41 Mn
Jun 30, 2025 41.00 Mn
Mar 31, 2025 38.91 Mn
Dec 31, 2024 45.00 Mn
Sep 30, 2024 58.00 Mn
Jun 30, 2024 32.89 Mn
Mar 31, 2024 30.00 Mn
API Access

Tyra Biosciences Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=TYRA&period=max&api_key=YOUR_API_KEY